Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: Upregulation during bacterial infections and viral meningitis

Journal of Neuroimmunology

Volumn 101, Issue 2, 1999, Pages 161-169

  Nockher, Wolfgang Andreas ^a   Wick, Manfred ^a   Pfister, Hans Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bacterial meningitis; Brain macrophage; Central nervous system; Cerebrospinal fluid; Inflammation; Soluble CD14 antigen; Viral meningitis

Indexed keywords

CD14 ANTIGEN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; INFLAMMATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VIRUS MENINGITIS;

ACUTE DISEASE; ANTIGENS, CD14; ENCEPHALITIS; HUMANS; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; SUPPURATION; UP-REGULATION;

EID: 0032721203     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00141-1     Document Type: Article

References (61)

1. Arditi M., Zhou J., Torres M., Durden D.L., Stins M., Kim K.S. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42 and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J. Immunol. 155:1995;3994-4003.
2. Bauer J., Ruuls S.R., Huitinga I., Dijkstra C.D. The role of macrophage subpopulations in autoimmune disease of the central nervous system. Histochem. J. 28:1996;83-97.
3. Bi Z., Barna M., Komatsu T., Reiss C.S. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:1995;6466-6472.
4. Blanco A., Solis G., Arranz E., Coto G.D., Ramos A., Telleria J. Serum levels of CD14 in neonatal sepsis by gram-positive and gram-negative bacteria. Acta Paediatr. 85:1996;728-732.
5. Bufler P., Stiegler G., Schuchmann M., Hess S., Krüger C., Stelter F., Eckerskorn C., Schütt C., Engelmann H. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur. J. Immunol. 25:1995;604-610.
6. Burgmann H., Winkler S., Locker J., Presterl E., Laczika K., Staudinger T., Knapp S., Thalhammer F., Wenisch C., Zedwitz-Liebenstein K., Frass M., Graninger W. Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin. Immunol. Immunopathol. 80:1996;307-310.
7. Cauwels A., Frei K., Sansano S., Fearns C., Ulevitch R., Zimmerli W., Landmann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J. Immunol. 162:1999;4762-4772.
8. Christian A.Y., Barna M., Bi Z., Reiss C.S. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol. 9:1996;195-205.
9. Cleveland M.G., Gorham J.D., Murphy T.L., Tuomanen E., Murphy K.M. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent mechanism pathway. Infect. Immun. 64:1996;1906-1912.
10. Delgado R., Carlin A., Airaghi L., Demitri M.T., Meda L., Galimberti D., Baron P., Lipton J.M., Catania A. Melanocortin peptides inhibit production of pro-inflammatory cytokines and nitric oxide by activated microglia. J. Leukocyte Biol. 63:1998;740-745.
11. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 392:1998;505-509.
12. Dooper I.M.M., Hoitsma A.J., Maass C.N., Assmann K.J.M., Tax W.J.M., Koene R.A.P., Bogman M.J.J.T. The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection. Transplantation. 58:1994;820-827.
13. Durieux J.J., Vita N., Popescu O., Guette F., Calzada Wack J., Munker R., Schmidt R.E., Lupker J., Ferrara P., Ziegler-Heitbrock H.W.L., Labeta M.O. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur. J. Immunol. 24:1994;2006-2012.
14. Felgenhauer, K., 1998. Labordiagnostik neurologischer Erkrankungen. In: Thomas, L. (Ed.), Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, TH-Books Verlagsgesellschaft, Frankfurt/Main, Germany, pp. 1341-1359.
15. Frey E.A., Miller D.S., Jahr T.G., Sundan A., Bazil V., Espevik T., Finlay B.B., Wright S.D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1992;1665-1671.
16. Gasque P., Singhrao S.K., Neal J.W., Gotze O., Morgan B.P. Expression of the receptor for complement C5a (CD88) is upregulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:1997;31-41.
17. Gegner J.A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide (LPS) signal transduction and clearance. J. Biol. Chem. 270:1995;5320-5325.
18. Griffin D.E., Levine B., Tyor W.R., Irani D.N. The immune response in viral encephalitis. Semin. Immunol. 4:1992;111-119.
19. + population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin. Exp. Immunol. 100:1995;291-297.
20. Guesdon J.L., Ternynck T., Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27:1979;1131-1139.
21. Hayashi J., Masaka T., Saito I., Ishikawa I. Soluble CD14 mediates lipopolysaccharide-induced adhesion molecule 1 expression in cultured human gingival fibroblasts. Infect. Immun. 64:1996;4946-4951.
22. Hayashi J., Masaka T., Ishikawa I. Increased levels of soluble CD14 in sera of peridontitis patients. Infect. Immun. 67:1999;417-420.
23. Haziot A., Rong G.W., Silver J., Goyert S.M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1993;1500-1507.
24. Hirata K., Shikata K., Matsuda M., Akiyama K., Sugimoto H., Kushiro M., Makino H. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologica. 41:1998;185-192.
25. Hoheisel G., Zheng L., Teschler H., Striz I., Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest. 108:1995;1614-1616.
26. Jackson A.M., Lien E., Alexandroff A.B., Prescott S., Espevik T., James K., Selby P.J., Sundan A. Soluble urinary CD14 after intravesical bacille Calmette-Guerin immunotherapy for carcinoma in situ. Br. J. Urol. 80:1997;766-771.
27. 2-) regulatory pathways. J. Immunol. 157:1996;2129-2135.
28. Juan T.S., Hailman E., Kelley M.J., Wright S.D., Lichenstein H.S. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signalling but not LPS binding. J. Biol. Chem. 270:1995;17237-17242.
29. Juffermans N.P., Verbon A., van Deventer S.J.H., Buurman W.A., Speelman, van Deutekom H., van der Poll T. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J. Infect. Dis. 178:1998;1839-1842.
30. Krüger C., Schütt C., Obertacke U., Joka T., Muller E., Knoller J., Koller M., König W., Schönfeld W. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:1991;297-301.
31. Kusunoki T., Hailman E., Juan T.S., Lichenstein H.S., Wright S.D. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune response. J. Exp. Med. 182:1995;1673-1682.
32. Lahrtz F., Piali L., Spanaus K.-S., Seebach J., Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J. Neuroimmunol. 85:1998;33-43.
33. Landmann R., Zimmerli W., Sansano S., Link S., Hahn A., Glauser M.P., Calandra T. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171:1995;639-644.
34. Landmann R., Knopf H.-P., Link S., Sansano S., Schumann R., Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect. Immun. 64:1996;1762-1769.
35. Lipovsky M.M., Gekker G., Anderson W.R., Molitor T.W., Peterson P.K., Hoepelman A.I.M. Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors. Clin. Immunol. Immunopathol. 84:1997;208-211.
36. Liu M.K., Herrera-Velit P., Brownsey R.W., Reiner N.E. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153:1994;2642-2653.
37. Lorenz H.M., Antoni C., Valerius T., Repp R., Grünke M., Schwerdtner N., Nüßlein H., Woody J., Kalden J.R., Manger B. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatic arthritis: short term cellular and molecular effects. J. Immunol. 156:1996;1646-1653.
38. Marquette C., van Dam A.M., Ceccaldi P.E., Weber P., Haour F., Tsiang H. Induction of immunoreactive interleukin-1 beta and tumor necrosis factor-alpha in the brains of rabies infected rats. J. Neuroimmunol. 68:1996;45-51.
39. Nockher W.A., Scherberich J.E. Monocyte cell surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int. 48:1995;1476-1569.
40. Nockher W.A., Bergmann L., Scherberich J.E. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98:1994;369-374.
41. Nockher W.A., Wigand R., Schoeppe W., Scherberich J.E. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 96:1994;15-19.
42. Oesterreicher C., Pfeffel F., Petermann D., Müller C. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J. Hepatol. 23:1995;396-402.
43. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., Pfister H.-W. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44:1998;592-600.
44. Perry V.H., Andersson P.-B., Gordon S. Macrophages and inflammation in the central nervous sytem. Trends Neurosci. 16:1993;268-273.
45. Peterson P.K., Gekker G., Hu S., Sheng W.S., Anderson W.R., Ulevitch R.J., Tobias P.S., Gustafson K.V., Molitor T.W., Chao C.C. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1995;1598-1602.
46. Peterson P.K., Gekker G., Hu S., Anderson W.R., Teichert M., Chao C.C., Molitor T.W. Multinucleated giant cell formation of swine microglia induced by Mycobacterium bovis. J. Infect. Dis. 173:1996;1194-1201.
47. Pfister H.-W., Scheld W.M. Brain injury in bacterial meningitis: therapeutic implications. Curr. Opin. Neurol. 10:1997;254-259.
48. Pugin J., Heumann I.D., Tomasz A., Kravchenko V.V., Akamatsu M.Y., Nishijima M., Glauser M.P., Tobias P.S., Ulevitch R.J. CD14 is a pattern recognition receptor. Immunity. 1:1994;509-516.
49. Rapoport S.I., Pettigrew K.D. A heterogenous, pore-vesicle membrane model for protein transfer from blood to cerebrospinal fluid at the choroid plexus. Microvasc. Res. 18:1979;105-119.
50. + monocyte-derived cells. Gut. 37:1995;367-373.
51. Scherberich J.E., Nockher W.A. Monocyte LPS receptor (CD14), HLA-DR expression and soluble CD14 (sCD14) in patients with acute and chronic infections. Shock. 7:1997;147. Suppl. 1.
52. Schlüter D., Käfer N., Hof H., Wiestler O.D., Deckert-Schlüter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 150:1997;1021-1035.
53. Schumann R.R., Pfeil D., Freyer D., Buerger W., Lamping N., Kirschning C.J., Goebel U.B., Weber J.R. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia. 22:1998;295-305.
54. Striz I., Zheng L., Wang Y.M., Pokorna H., Bauer P.C., Costabel U. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am. J. Respir. Crit. Care Med. 151:1995;544-547.
55. Tobias P.S., Soldau K., Kline L., Kato K., Martin T.P., Ulevitch R.J. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:1993;3011-3021.
56. Tomita M., Yamamoto K., Kobashi H., Ohmoto M., Tsuji T. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology. 20:1994;317-325.
57. Virchow J.C., Julius P., Matthys H., Kroegel C., Luttmann W. CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. Eur. Respir. J. 11:1998;317-323.
58. Weckerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9:1986;271-277.
59. Wenisch C., Wenisch H., Parschalk B., Vanijanonta S., Burgmann H., Exner M., Zedwitz-Liebenstein K., Thalhammer F., Georgopoulos A., Graninger W., Looareesuwan S. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin. Exp. Immunol. 105:1996;74-78.
60. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
61. Ziegler-Heitbrock H.W.L., Ulevitch R.J. CD14: cell surface receptor and differentiation marker. Immunol. Today. 14:1993;121-125.